Ceftazidime
Brand names: AVYCAZ (in combination) FORTAZ TAZICEF
Therapeutic Indications
Ceftazidime is indicated for:
Broncho-pulmonary infections in cystic fibrosis
Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 150 mg/kg in 3 divided doses daily
Treatment 2: Intramuscular - 150 mg/kg in 3 divided doses daily
Treatment 3: Intravenous - 100-200 mg/kg continuous infusion daily
Bone and joint infections, complicated skin and soft tissue infections
Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 100-150 mg/kg in 3 divided doses daily
Treatment 2: Intramuscular - 100-150 mg/kg in 3 divided doses daily
Treatment 3: Intravenous - 100-200 mg/kg continuous infusion daily
Chronic purulent otitis media, malignant otitis externa
Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 100-150 mg/kg in 3 divided doses daily
Treatment 2: Intramuscular - 100-150 mg/kg in 3 divided doses daily
Complicated intra-abdominal infections
Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 100-150 mg/kg in 3 divided doses daily
Treatment 2: Intramuscular - 100-150 mg/kg in 3 divided doses daily
Treatment 3: Intravenous - 100-200 mg/kg continuous infusion daily
Peritonitis associated with dialysis in patients on CAPD
Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 100-150 mg/kg in 3 divided doses daily
Treatment 2: Intramuscular - 100-150 mg/kg in 3 divided doses daily
Treatment 3: Intravenous - 100-200 mg/kg continuous infusion daily
Febrile neutropenia
Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 150 mg/kg in 3 divided doses daily
Treatment 2: Intramuscular - 150 mg/kg in 3 divided doses daily
Treatment 3: Intravenous - 100-200 mg/kg continuous infusion daily
Nosocomial pneumonia
Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 100-200 mg/kg continuous infusion daily
Complicated urinary tract infections
Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 100-150 mg/kg in 3 divided doses daily
Treatment 2: Intramuscular - 100-150 mg/kg in 3 divided doses daily
Bacterial meningitis
Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 150 mg/kg in 3 divided doses daily
Treatment 2: Intramuscular - 150 mg/kg in 3 divided doses daily
Treatment 3: Intravenous - 100-200 mg/kg continuous infusion daily
Bacterial infections
Irrespective of gender only Newborns (0 - 40 days old)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 25-60 mg/kg in 2 divided doses daily
Broncho-pulmonary infections in cystic fibrosis
Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 100-150 mg/kg in 3 divided doses daily
Treatment 2: Intramuscular - 100-150 mg/kg in 3 divided doses daily
Treatment 3: Intravenous - 4-6 g continuous infusion daily
Bone and joint infections, complicated skin and soft tissue infections
Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 3-6 g in 3 divided doses daily
Treatment 2: Intramuscular - 3-6 g in 3 divided doses daily
Treatment 3: Intravenous - 4-6 g continuous infusion daily
Chronic purulent otitis media, malignant otitis externa
Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 3-6 g in 3 divided doses daily
Treatment 2: Intramuscular - 3-6 g in 3 divided doses daily
Complicated intra-abdominal infections
Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 3-6 g in 3 divided doses daily
Treatment 2: Intramuscular - 3-6 g in 3 divided doses daily
Treatment 3: Intravenous - 4-6 g continuous infusion daily
Peri-operative prophylaxis for transuretheral resection of prostate (TURP)
Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 1 g once
Peritonitis associated with dialysis in patients on CAPD
Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 3-6 g in 3 divided doses daily
Treatment 2: Intramuscular - 3-6 g in 3 divided doses daily
Treatment 3: Intravenous - 4-6 g continuous infusion daily
Febrile neutropenia
Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 6 g in 3 divided doses daily
Treatment 2: Intramuscular - 6 g in 3 divided doses daily
Treatment 3: Intravenous - 4-6 g continuous infusion daily
Nosocomial pneumonia
Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 6 g in 3 divided doses daily
Treatment 2: Intramuscular - 6 g in 3 divided doses daily
Treatment 3: Intravenous - 4-6 g continuous infusion daily
Complicated urinary tract infections
Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 2-6 g in 2-3 divided doses daily
Treatment 2: Intramuscular - 2-6 g in 2-3 divided doses daily
Bacterial meningitis
Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Intravenous - 6 g in 3 divided doses daily
Treatment 2: Intramuscular - 6 g in 3 divided doses daily
Treatment 3: Intravenous - 4-6 g continuous infusion daily
Contraindications
Active ingredient Ceftazidime is contraindicated in the following cases:
Hypersensitivity to cephalosporins
No gender/age discrimination
Hypersensitivity to the active substance, to any other cephalosporin.